Marshall Wace North America’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$284K Buy
2,474
+308
+14% +$32.7K ﹤0.01% 1259
2021
Q2
$210K Sell
2,166
-5,118
-70% -$444K ﹤0.01% 1339
2021
Q1
$536K Sell
7,284
-2,238
-24% -$166K ﹤0.01% 1182
2020
Q4
$650K Buy
+9,522
New +$621K ﹤0.01% 1031
2019
Q3
Sell
-15,429
Closed -$837K 1297
2019
Q2
$837K Buy
+15,429
New +$783K 0.01% 796
2019
Q1
Sell
-1,316
Closed -$75K 1537
2018
Q4
$75K Buy
+1,316
New +$73.8K ﹤0.01% 1141
2017
Q3
Sell
-6,467
Closed -$252K 1230
2017
Q2
$252K Buy
+6,467
New +$248K ﹤0.01% 1186
2013
Q4
$1.57M Buy
+106,643
New +$1.44M 0.03% 319

Other funds holding AMN

Marshall Wace North America's AMN Position: Q3 2021 in Review

Marshall Wace North America increased its AMN Healthcare (AMN) stake by 14% in Q3 2021, buying an estimated $32.7K and bringing the position to 2,474 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Marshall Wace North America first reported a position in AMN in Q4 2013 and has held it in 8 quarters since. The position peaked at $1.57M in Q4 2013. 374 funds tracked by Wall St. Rank hold AMN as of Q3 2021.

  • Marshall Wace North America held 2,474 shares of AMN Healthcare worth $284K as of Q3 2021.
  • Marshall Wace North America bought 308 AMN Healthcare shares in Q3 2021, an estimated $32.7K.
  • AMN Healthcare made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1259 holding.
  • Marshall Wace North America first reported a position in AMN Healthcare in Q4 2013 and has held it in 8 quarters since.
  • Marshall Wace North America's AMN Healthcare position peaked at $1.57M in Q4 2013.
  • 374 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.